Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

Post by modulexon Jan 05, 2016 3:54pm
147 Views
Post# 24431213

DIAGNOCURE-HOLOGIC

DIAGNOCURE-HOLOGICHOLOGIC REQUESTED TO PAY AT LEAST $11M FOR DIAGNOCURE PCA3 ASSET SALE MONTREAL QC. (CANADA) JANUARY 5, 2016 HOLOGIC INC.S PRESIDENT AND CEO STEPHEN MACMILLAN IS BEING PRESSED TO STEP UP TO THE PLATE AND OFFER TINY MOLECULAR CANCER TESTS COMPANY DIAGNOCURE INC. A MINIMAL AMOUNT OF $11 MILLION FOR PURCHASING THE QUEBEC CITY- BASED PCA3 ASSET. HOLOGIC INITIALLY AGREED TO PAY CAD $5.5 MILLION FOR THE TRANSACTION BUT WAS FIERCELY TURNED DOWN BY A DIAGNOCURE SHAREHOLDER WHO DEMONSTRATED THAT THE POTENTIAL VALUE OF FUTURE SALES OF THE ASSET IS NEGLECTED IN HOLOGICS OFFER. - 30 -
<< Previous
Bullboard Posts
Next >>